Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Se

americanpharmaceuticalreviewFebruary 15, 2017

Tag: European Commission , Active Rheumatoid Arthritis

PharmaSources Customer Service